Characterization of CD4 T Cell Epitopes of Infliximab and Rituximab Identified from Healthy Donors

Overview of attention for article published in Frontiers in immunology, May 2017

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (63rd percentile)
Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

So far, Altmetric has seen 7 X posts from 7 X users, with an upper bound of 60,480 followers.

RT @FrontImmunol: Characterization of CD4 T Cell Epitopes of Infliximab and Rituximab Identified from Healthy Donors: Moustafa Hamze,… http…

RT @FrontImmunol: Characterization of CD4 T Cell Epitopes of Infliximab and Rituximab Identified from Healthy Donors: Moustafa Hamze,… http…

RT @FrontImmunol: Characterization of CD4 T Cell Epitopes of Infliximab and Rituximab Identified from Healthy Donors: Moustafa Hamze,… http…

RT @FrontImmunol: Characterization of CD4 T Cell Epitopes of Infliximab and Rituximab Identified from Healthy Donors: Moustafa Hamze,… http…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.